| 达安基因 (002030) 财务指标 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 每股收益 | 每股净资产 | 每股经营性 现金流 |
每股公积金 | 每股 未分配利润 |
总资产 利润率 |
主营业务利润率 | 总资产净利润率 | 成本费用利润率 | 营业利润率 | 主营业务 成本率 |
主营利润 比重 |
净资产 收益率 |
主营业务 收入增长率 |
净利润 增长率 |
总资产 增长率 |
应收帐款 周转率 |
存货周转 天数 |
存货周转率 | 总资产周转率 | 股东权益 周转率 |
流动比率 | 速动比率 | 现金比率 | 股东权益 比率 |
长期负债 比率 |
股东权益与 固定资产比率 |
资产负债率 | 经营现金净流量 对销售收入比率 |
资产的经营现金流 量回报率 |
经营现金净流量与 净利润的比率 |
经营现金净流量 对负债比率 |
现金流量比率 |
| 2026-03-31 | -0.07 | 5.02 | -0.03 | 0.4287 | 2.6854 | -1.1782 | 29.645 | -1.1659 | -55.6299 | -66.4437 | -44.3701 | -1.38 | -11.6458 | -291.5543 | -12.1537 | 0.2041 | 0.702 | 0.0177 | 0.0204 | 2.9803 | 2.8236 | 65.9197 | 87.1911 | 0 | -- | 12.8089 | -0.3054 | -0.0055 | -- | -0.0427 | -4.8576 | ||
| 2025-12-31 | -0.07 | 5.02 | -0.03 | 0.4287 | 2.7554 | -9.1713 | 30.9078 | -8.6305 | -87.1532 | -99.4314 | -30.9353 | -1.38 | -11.1793 | 0 | -11.1352 | 0.7577 | 2.9623 | 0.0838 | 0.0977 | 2.8227 | 2.6762 | 57.5139 | 86.5375 | 0 | 463.8204 | 13.4625 | 0.4217 | 0.0375 | -- | 0.2789 | 31.7144 | ||
| 2025-09-30 | -0.07 | 5.02 | -0.03 | 0.4301 | 3.1849 | -1.658 | 31.9822 | -1.6151 | -29.5033 | -32.8495 | -94.9635 | -1.38 | -14.8115 | 0 | -8.9168 | 0.4863 | 1.7284 | 0.0539 | 0.0624 | 3.0587 | 2.8521 | 62.2721 | 87.9117 | 0 | -- | 12.0883 | 0.1619 | 0.009 | -- | 0.0742 | 8.675 | ||
| 2025-06-30 | -0.07 | 5.02 | -0.03 | 0.4301 | 3.156 | -2.0854 | 32.2922 | -2.0341 | -57.0767 | -63.9055 | -49.8819 | -1.38 | -15.4371 | 0 | -9.9673 | 0.3045 | 1.1769 | 0.0362 | 0.0421 | 2.9949 | 2.8104 | 53.0983 | 87.2536 | 0 | 705.235 | 12.7464 | -0.0314 | -0.0012 | -- | -0.0092 | -1.0494 | ||
| 2025-03-31 | -0.07 | 5.02 | -0.03 | 0.4282 | 3.3235 | 0.5403 | 30.4721 | 0.5378 | 50.931 | 55.0897 | 54.929 | -1.38 | -14.71 | 0 | -8.5487 | 0.1394 | 0.5819 | 0.0177 | 0.0207 | 2.9143 | 2.7351 | 81.7029 | 86.3682 | 0 | -- | 13.6318 | -0.2169 | -0.0039 | -0.7158 | -0.0284 | -3.2444 | ||
| 2024-12-31 | -0.07 | 5.02 | -0.03 | 0.4282 | 3.2858 | -9.806 | 36.4289 | -9.1199 | -128.6843 | -125.1553 | -29.0102 | -1.38 | -27.7647 | -1409.2041 | -13.0787 | 0.5151 | 2.4341 | 0.0828 | 0.0986 | 2.9229 | 2.7697 | 73.0306 | 85.0276 | 0 | 644.0192 | 14.9724 | 0.3521 | 0.0314 | -- | 0.2095 | 23.2142 | ||
| 2024-09-30 | -0.07 | 5.02 | -0.03 | 0.4408 | 3.5868 | -5.0231 | 39.267 | -4.7758 | -107.4212 | -95.8907 | -40.8693 | -1.38 | -29.8321 | -244.8995 | -11.7249 | 0.3358 | 1.4848 | 0.0563 | 0.0666 | 4.0965 | 3.9027 | 70.6092 | 86.1562 | 0 | -- | 13.8438 | 0.224 | 0.0133 | -- | 0.0958 | 10.7653 | ||
| 2024-06-30 | -0.07 | 5.02 | -0.03 | 0.4507 | 3.6605 | -3.9269 | 40.5226 | -3.7613 | -141.9218 | -118.5713 | -34.0839 | -1.38 | -25.3324 | -199.8125 | -13.5168 | 0.2138 | 0.946 | 0.0379 | 0.0448 | 4.1534 | 3.9491 | 69.4617 | 86.1104 | 0 | 659.7703 | 13.8896 | 0.0498 | 0.002 | -- | 0.0142 | 1.5795 | ||
| 2024-03-31 | -0.07 | 5.02 | -0.03 | 0.4642 | 3.7011 | -3.4811 | 55.2189 | -3.3764 | -286.4185 | -218.5023 | -25.2272 | -1.38 | -41.8518 | -1055.9577 | -25.0133 | 0.1009 | 0.3569 | 0.0185 | 0.0221 | 3.7384 | 3.5675 | 61.5435 | 84.7866 | 0 | -- | 15.2134 | -0.4528 | -0.0087 | -- | -0.0569 | -6.1078 | ||
| 2023-12-31 | -0.07 | 5.02 | -0.03 | 0.4642 | 3.96 | 0.651 | 49.6391 | 0.5566 | 13.6608 | 10.2991 | 516.3001 | -1.38 | -90.1969 | -98.6784 | -25.3381 | 0.3857 | 1.9206 | 0.0916 | 0.1137 | 3.0853 | 2.9461 | 64.2456 | 83.1107 | 0 | 641.6693 | 16.8893 | 0.6606 | 0.0708 | 10.8754 | 0.4192 | 45.3266 | ||
| 2023-09-30 | -0.07 | 5.02 | -0.03 | 0.4699 | 4.1519 | 3.0601 | 54.2561 | 2.6555 | 71.5648 | 51.2306 | 106.3867 | -1.38 | -90.9774 | -92.9714 | -18.3308 | 0.2572 | 1.009 | 0.0646 | 0.08 | 2.9418 | 2.717 | 62.8667 | 83.5178 | 0 | -- | 16.4822 | 0.3374 | 0.0251 | 0.8212 | 0.1525 | 16.5951 | ||
| 2023-06-30 | -0.07 | 5.02 | -0.03 | 0.4699 | 4.1876 | 3.4025 | 52.3735 | 3.0106 | 121.1307 | 91.2129 | 57.6297 | -1.38 | -91.968 | -88.9575 | -10.8073 | 0.1533 | 0.6364 | 0.0405 | 0.0508 | 2.4706 | 2.2633 | 46.2625 | 81.1185 | 0 | 675.7958 | 18.8815 | -0.0716 | -0.0033 | -0.0963 | -0.0174 | -1.876 | ||
| 达安基因 (002030) 利润表 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 营业收入 | 营业支出 | 销售费用 | 管理费用 | 财务费用 | 营业利润 | 利润总额 | 净利润 | ||||
| 2026-03-31 | 14943.93 | 20515.63 | 4495.96 | 3209.61 | -271.31 | -9929.29 | -9984.48 | -9819.62 | ||||
| 2025-12-31 | 75766.19 | 105491.49 | 22344.35 | 15781.62 | -3617.26 | -75335.39 | -75698.85 | -78052.20 | ||||
| 2025-09-30 | 50350.69 | 72064.39 | 15772.74 | 10416.81 | -2960.96 | -16539.96 | -16957.33 | -15077.49 | ||||
| 2025-06-30 | 33857.40 | 48871.20 | 10719.08 | 6705.44 | -1947.04 | -21636.75 | -21918.36 | -19012.46 | ||||
| 2025-03-31 | 16913.66 | 23817.58 | 4535.46 | 3156.24 | -1028.62 | 9317.68 | 9382.92 | 5126.28 | ||||
| 2024-12-31 | 85302.43 | 105806.45 | 20813.53 | 14705.25 | -6506.89 | -106760.55 | -107116.34 | -93911.29 | ||||
| 2024-09-30 | 59105.01 | 69578.00 | 10581.02 | 11168.12 | -4780.84 | -56676.21 | -56787.76 | -50150.16 | ||||
| 2024-06-30 | 40038.14 | 45431.23 | 6299.58 | 6805.63 | -3378.17 | -47473.73 | -47601.56 | -39764.58 | ||||
| 2024-03-31 | 19830.77 | 20795.15 | 2541.90 | 5341.44 | -1608.76 | -43330.69 | -43406.81 | -36114.09 | ||||
| 2023-12-31 | 118089.71 | 113344.08 | 17283.33 | 13831.34 | -7474.89 | 12162.19 | 11353.59 | 7173.16 | ||||
| 2023-09-30 | 84233.62 | 82299.53 | 13565.39 | 14063.30 | -6133.33 | 43153.39 | 42958.29 | 34610.31 | ||||
| 2023-06-30 | 53621.84 | 55421.07 | 10247.08 | 9785.35 | -5340.38 | 48910.02 | 48731.20 | 39839.27 | ||||
| 达安基因 (002030) 资产负债表 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 货币资金 | 应收帐款 | 预付款项 | 其它应收款 | 流动资产合计 | 非流动资产合计 | 资产总计 | 流动负债合计 | 非流动负债合计 | 负债合计 | 股东权益合计 | 负债及股东权益总计 |
| 2026-03-31 | 51239.15 | 71911.87 | 1589.59 | -- | 553474.18 | 553474.18 | 833447.90 | 12813.20 | 12813.20 | 106755.41 | 703966.59 | 833447.90 |
| 2025-12-31 | 50629.47 | 74554.00 | 2049.30 | -- | 566691.58 | 566691.58 | 851050.64 | 13833.34 | 13833.34 | 114572.72 | 713786.10 | 851050.64 |
| 2025-09-30 | 49103.88 | 81645.94 | 4539.05 | -- | 621951.18 | 621951.18 | 909368.42 | 15958.39 | 15958.39 | 109926.89 | 774070.48 | 909368.42 |
| 2025-06-30 | 46067.73 | 96938.91 | 4346.88 | 3496.77 | 607965.82 | 607965.82 | 911698.36 | 14791.14 | 14791.14 | 116208.80 | 769988.18 | 911698.36 |
| 2025-03-31 | 85129.60 | 117153.46 | 5928.14 | -- | 619155.27 | 619155.27 | 948757.23 | 16234.97 | 16234.97 | 129332.68 | 793285.11 | 948757.23 |
| 2024-12-31 | 87208.61 | 125434.48 | 4982.60 | 3362.06 | 579540.10 | 579540.10 | 957691.57 | 14014.78 | 14014.78 | 143389.46 | 787994.92 | 957691.57 |
| 2024-09-30 | 77344.12 | 146205.96 | 5620.53 | -- | 494500.37 | 494500.37 | 998392.78 | 15209.42 | 15209.42 | 138215.19 | 832376.24 | 998392.78 |
| 2024-06-30 | 75626.49 | 168781.43 | 4582.51 | 3941.79 | 488029.83 | 488029.83 | 1012629.71 | 14343.16 | 14343.16 | 140650.15 | 844135.00 | 1012629.71 |
| 2024-03-31 | 79847.27 | 187241.52 | 4899.14 | -- | 487813.38 | 487813.38 | 1037445.66 | 10807.78 | 10807.78 | 157830.99 | 851716.78 | 1037445.66 |
| 2023-12-31 | 99937.25 | 205782.79 | 4298.91 | 4385.13 | 570782.89 | 570782.89 | 1101791.69 | 13976.16 | 13976.16 | 186084.98 | 888023.48 | 1101791.69 |
| 2023-09-30 | 100454.58 | 248518.41 | 10469.13 | -- | 627150.00 | 627150.00 | 1131001.33 | 15141.36 | 15141.36 | 186414.40 | 913739.54 | 1131001.33 |
| 2023-06-30 | 86679.05 | 292951.15 | 12315.51 | 5194.66 | 665426.24 | 665426.24 | 1170897.17 | 16487.31 | 16487.31 | 221083.52 | 918750.05 | 1170897.17 |
| 达安基因 (002030) 现金流量表 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 经营活动现金流入小计 | 经营活动现金流出小计 | 经营活动产生的现金流量净额 | 投资活动现金流入小计 | 投资活动现金流出小计 | 投资活动产生的现金流量净额 | 取得借款收到的现金 | 发行债券收到的现金 | 筹资活动现金流入小计 | 筹资活动现金流出小计 | 筹资活动产生的现金流量净额 | |
| 2026-03-31 | 31284.94 | 35848.30 | -4563.36 | 30962.29 | 27235.88 | 3726.41 | 4897.90 | -- | 4947.90 | 3356.34 | 1591.56 | |
| 2025-12-31 | 190118.13 | 158169.20 | 31948.93 | 185877.80 | 249609.58 | -63731.78 | 12300.86 | -- | 12791.08 | 17246.44 | -4455.36 | |
| 2025-09-30 | 133652.78 | 125500.99 | 8151.79 | 126043.74 | 167742.51 | -41698.77 | 8251.15 | -- | 9741.15 | 13772.04 | -4030.89 | |
| 2025-06-30 | 84618.12 | 85682.38 | -1064.26 | 84300.65 | 118580.41 | -34279.77 | 4336.09 | -- | 5326.09 | 10641.93 | -5315.85 | |
| 2025-03-31 | 42740.43 | 46409.82 | -3669.39 | 58096.18 | 53724.71 | 4371.47 | 2779.00 | -- | 2779.00 | 5548.82 | -2769.82 | |
| 2024-12-31 | 241717.36 | 211684.09 | 30033.27 | 157168.24 | 178907.53 | -21739.29 | 14785.28 | -- | 19465.28 | 40060.78 | -20595.50 | |
| 2024-09-30 | 164897.35 | 151655.36 | 13241.99 | 68223.62 | 84526.94 | -16303.31 | 9158.07 | -- | 13838.07 | 33041.17 | -19203.10 | |
| 2024-06-30 | 112952.42 | 110957.37 | 1995.04 | 37177.93 | 40804.17 | -3626.24 | 4499.72 | -- | 8479.72 | 30970.90 | -22491.17 | |
| 2024-03-31 | 51765.23 | 60745.09 | -8979.87 | 13792.90 | 23970.58 | -10177.67 | 2756.68 | -- | 3756.68 | 4526.05 | -769.37 | |
| 2023-12-31 | 435355.96 | 357344.84 | 78011.11 | 233898.39 | 240267.45 | -6369.06 | 31852.22 | -- | 35352.22 | 267679.15 | -232326.92 | |
| 2023-09-30 | 350766.34 | 322343.35 | 28422.99 | 217471.20 | 175994.85 | 41476.34 | 27281.89 | -- | 29286.93 | 258815.71 | -229528.78 | |
| 2023-06-30 | 248758.25 | 252596.50 | -3838.25 | 209976.86 | 153753.70 | 56223.17 | 25755.29 | -- | 27755.29 | 254073.22 | -226317.93 | |
| 达安基因 (002030) 最新业绩预告 查看：历史业绩预告 | |
|---|---|
| 公告日期 | 2026-01-31 |
| 报告期 | 2025-12-31 |
| 类型 | |
| 业绩摘要 | 预计2025年1-12月归属于上市公司股东的净利润为：-60700万元至-86500万元。 |
| 上年同期每股收益(元) | -0.66 |
| 行业 | 医疗器械 |
| 概念 | 养老产业,基因测序,医疗器械,流感,精准医疗,高校系,体外诊断,科创板概念股,创投 |
| 账务标签 | |
| 账务评述 | 财务面不确定！ |